Is Padcev covered by Medicare?

Yes. Padcev (J9177) is covered under Medicare Part B as a physician-administered drug when billed for a medically necessary indication. There is no drug-specific Local Coverage Determination (LCD) for it, so coverage is determined per medical necessity by your MAC; the FDA-approved indications below are the starting point. None of the 8 Medicare Administrative Contractors lists J9177 as self-administered.

What diagnoses are covered for Padcev (J9177)?

Medicare publishes no drug-specific covered-diagnosis list for J9177. The 12 ICD-10 codes here are the FDA-approved indications; an off-label use needs approved-compendium support (DrugDex, NCCN) to be payable.

Which Medicare policy covers Padcev?

No drug-specific LCD or Billing & Coding Article exists for Padcev. It's covered under the general Medicare Part B drug benefit per medical necessity, as judged by your Medicare Administrative Contractor (MAC).

Why was my Padcev claim denied as not medically necessary?

The most common cause is a diagnosis the MAC doesn't consider medically necessary for J9177. Bill a covered/FDA-approved indication from the list below, document medical necessity, and confirm any local guidance with your MAC.

Padcev (J9177) Medicare Coverage & FDA Indications

Page reviewed Aug 23, 2026 · from FDA-approved labeling (Drugs@FDA) — no drug-specific Medicare LCD

Quick answer

Medicare benefit

Part B (physician-administered)

FDA-indicated diagnoses

12 ICD-10 codes

Governing policy

FDA indications (no LCD)

Contractor (MAC)

Per medical necessity

Source

FDA labeling

Page reviewed

Aug 23, 2026

HCPCS codes covered:
J9177

No drug-specific Medicare coverage article exists for Padcev. Coverage is decided per medical necessity by your MAC. The FDA-approved indications below are the labeled uses Medicare generally pays for; an off-label use may be covered if supported by an approved compendium. Find your MAC by state →

What Medicare pays for Padcev (2026 Q4)

2026 Q4 payment limit per billing unit for Padcev’s HCPCS code (how ASP + 6% works):

HCPCS	Description	Per unit	Allowed (ASP + 6%)
J9177	Inj enfort vedo-ejfv 0.25mg	0.25 mg	$36.535

CMS ASP Drug Pricing File, 2026 Q4. Padcev patient out-of-pocket estimate →

Padcev (HCPCS J9177) is paid under Part B only when the claim’s ICD-10 code is one the MAC accepts; otherwise expect a CO-50 denial. How Part B drug coverage is decided →

Covered ICD-10 diagnoses for Padcev

The 12 FDA-approved indications for J9177, grouped by condition — filter to find a code.

Urothelial Carcinoma — 3 diagnoses (applies to J9177)

Neoplasms (3)

ICD-10	Covered diagnosis
C65.9	Malignant neoplasm of unspecified renal pelvis
C67.0	Malignant neoplasm of trigone of bladder
C67.9	Malignant neoplasm of bladder, unspecified

Encounter — 1 diagnoses (applies to J9177)

Factors influencing health status (1)

ICD-10	Covered diagnosis
Z51.11	Encounter for antineoplastic chemotherapy

Bladder Cancer — 8 diagnoses (applies to J9177)

Neoplasms (8)

ICD-10	Covered diagnosis
C67.1	Malignant neoplasm of dome of bladder
C67.2	Malignant neoplasm of lateral wall of bladder
C67.3	Malignant neoplasm of anterior wall of bladder
C67.4	Malignant neoplasm of posterior wall of bladder
C67.5	Malignant neoplasm of bladder neck
C67.6	Malignant neoplasm of ureteric orifice
C67.7	Malignant neoplasm of urachus
C67.8	Malignant neoplasm of overlapping sites of bladder

How to bill Padcev

Put a medically necessary, FDA-indicated diagnosis from the list above on the claim line with J9177. Matching codes, units and JZ/JW wastage →

Which policy governs Padcev

No drug-specific LCD or Article — see the note at the top of this page. Find your MAC → What an LCD, an Article and an NCD each govern →

If a claim for Padcev is denied

With no drug-specific Article, the usual cause is a diagnosis the MAC does not accept as medically necessary for J9177, or an off-label use with no compendium support. The five denial patterns and how to fix each →

Frequently asked questions

Is Padcev covered by Medicare?: Yes. Padcev (J9177) is covered under Medicare Part B as a physician-administered drug when billed for a medically necessary indication. There is no drug-specific Local Coverage Determination (LCD) for it, so coverage is determined per medical necessity by your MAC; the FDA-approved indications below are the starting point. None of the 8 Medicare Administrative Contractors lists J9177 as self-administered.
What diagnoses are covered for Padcev (J9177)?: Medicare publishes no drug-specific covered-diagnosis list for J9177. The 12 ICD-10 codes here are the FDA-approved indications; an off-label use needs approved-compendium support (DrugDex, NCCN) to be payable.
Which Medicare policy covers Padcev?: No drug-specific LCD or Billing & Coding Article exists for Padcev. It's covered under the general Medicare Part B drug benefit per medical necessity, as judged by your Medicare Administrative Contractor (MAC).
Why was my Padcev claim denied as not medically necessary?: The most common cause is a diagnosis the MAC doesn't consider medically necessary for J9177. Bill a covered/FDA-approved indication from the list below, document medical necessity, and confirm any local guidance with your MAC.

Related references

Covered is only half the answer.

You know the diagnosis is payable. Now quote the patient before the visit and catch underpayments: get Padcev's exact Medicare allowed amount, your payer's rate vs. ASP+6%, and the patient's out-of-pocket — in about 30 seconds, free.

Estimate Padcev cost & patient owe →

Source & verification

Source: FDA-approved indications (Drugs@FDA labeling) mapped to ICD-10-CM. No drug-specific Medicare LCD/Article exists for Padcev — Part B coverage is determined per medical necessity by your MAC.
Primary sources: DailyMed — Padcev prescribing information · CMS Part B Drug ASP Pricing File — the quarterly payment limit quoted above · CMS Medicare Coverage Database — searched for “Padcev”; no drug-specific NCD, LCD or Billing & Coding Article exists, which is why the FDA-indicated codes above are the working list
Page last reviewed by CareCost: Aug 23, 2026 (coverage data retrieved 2026-09-21; we re-verify against CMS quarterly).
Notes: ICD-10-CM is public domain; CPT® (AMA) is intentionally not listed. Reference, not billing advice — built from the CMS Coverage API per our methodology; corrections to editorial@carecostestimate.com.